

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of B cell proliferation (GO:0030889) | 5.74630875 |
| 2 | regulation of chronic inflammatory response (GO:0002676) | 5.41340449 |
| 3 | detection of other organism (GO:0098543) | 5.27624306 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.10392339 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.10392339 |
| 6 | positive regulation of respiratory burst (GO:0060267) | 5.08572225 |
| 7 | microglial cell activation (GO:0001774) | 4.95921785 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.90756955 |
| 9 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.89178511 |
| 10 | response to peptidoglycan (GO:0032494) | 4.76360834 |
| 11 | detection of bacterium (GO:0016045) | 4.75552618 |
| 12 | regulation of regulatory T cell differentiation (GO:0045589) | 4.71891173 |
| 13 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.70030431 |
| 14 | cellular extravasation (GO:0045123) | 4.66083847 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 4.65210436 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.63754169 |
| 17 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.34951129 |
| 18 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.32180179 |
| 19 | response to host immune response (GO:0052572) | 4.30779405 |
| 20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.30779405 |
| 21 | detection of biotic stimulus (GO:0009595) | 4.30098348 |
| 22 | macrophage activation (GO:0042116) | 4.23174511 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.15085874 |
| 24 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.12579892 |
| 25 | regulation of growth of symbiont in host (GO:0044126) | 4.12579892 |
| 26 | negative regulation of growth of symbiont in host (GO:0044130) | 4.12579892 |
| 27 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.12579892 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 4.09062654 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.08434654 |
| 30 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.06737746 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.04532345 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 3.96937270 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.95914392 |
| 34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.95555684 |
| 35 | response to host (GO:0075136) | 3.95555684 |
| 36 | response to host defenses (GO:0052200) | 3.95555684 |
| 37 | respiratory burst (GO:0045730) | 3.91492259 |
| 38 | positive regulation of mast cell activation (GO:0033005) | 3.89525469 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.87805643 |
| 40 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.81004091 |
| 41 | detection of molecule of bacterial origin (GO:0032490) | 3.78744827 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.76401316 |
| 43 | neutrophil activation (GO:0042119) | 3.74390863 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.68904555 |
| 45 | regulation of mast cell degranulation (GO:0043304) | 3.55308326 |
| 46 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.54811178 |
| 47 | negative regulation of B cell activation (GO:0050869) | 3.54044798 |
| 48 | tolerance induction (GO:0002507) | 3.52960789 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.52128575 |
| 50 | response to type I interferon (GO:0034340) | 3.49983582 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.48645891 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.48638874 |
| 53 | cellular response to type I interferon (GO:0071357) | 3.47144263 |
| 54 | type I interferon signaling pathway (GO:0060337) | 3.47144263 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.43699838 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.42085974 |
| 57 | negative regulation of cell killing (GO:0031342) | 3.42085974 |
| 58 | growth hormone receptor signaling pathway (GO:0060396) | 3.41949388 |
| 59 | granulocyte activation (GO:0036230) | 3.39873141 |
| 60 | positive thymic T cell selection (GO:0045059) | 3.38903961 |
| 61 | regulation of mast cell activation (GO:0033003) | 3.37010259 |
| 62 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.36880959 |
| 63 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.36867444 |
| 64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.36851005 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.35627616 |
| 66 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.33559620 |
| 67 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.31522661 |
| 68 | cellular defense response (GO:0006968) | 3.31381330 |
| 69 | regulation of tolerance induction (GO:0002643) | 3.31335555 |
| 70 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.30364131 |
| 71 | positive regulation of mast cell degranulation (GO:0043306) | 3.30364131 |
| 72 | myeloid leukocyte mediated immunity (GO:0002444) | 3.30129982 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.29189588 |
| 74 | B cell mediated immunity (GO:0019724) | 3.27713360 |
| 75 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.26857857 |
| 76 | positive regulation of interferon-alpha production (GO:0032727) | 3.26507296 |
| 77 | T-helper 1 type immune response (GO:0042088) | 3.26047390 |
| 78 | activated T cell proliferation (GO:0050798) | 3.25575808 |
| 79 | cellular response to interferon-alpha (GO:0035457) | 3.25129640 |
| 80 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.22756478 |
| 81 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.22583098 |
| 82 | opsonization (GO:0008228) | 3.19474159 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19011353 |
| 84 | positive regulation of B cell differentiation (GO:0045579) | 3.18905983 |
| 85 | regulation of B cell differentiation (GO:0045577) | 3.16506496 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 3.15029777 |
| 87 | angiogenesis involved in wound healing (GO:0060055) | 3.12536978 |
| 88 | dendritic cell migration (GO:0036336) | 3.12039203 |
| 89 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.11364852 |
| 90 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.10884480 |
| 91 | T-helper cell differentiation (GO:0042093) | 3.10457824 |
| 92 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.10457824 |
| 93 | response to muramyl dipeptide (GO:0032495) | 3.07969242 |
| 94 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.07195931 |
| 95 | regulation of B cell proliferation (GO:0030888) | 3.06240502 |
| 96 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.05883861 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.05388837 |
| 98 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04209683 |
| 99 | positive T cell selection (GO:0043368) | 3.02213550 |
| 100 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.00419743 |
| 101 | T cell migration (GO:0072678) | 2.97891139 |
| 102 | defense response to protozoan (GO:0042832) | 2.97438840 |
| 103 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96023813 |
| 104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95993801 |
| 105 | leukocyte aggregation (GO:0070486) | 2.93862835 |
| 106 | dendritic cell chemotaxis (GO:0002407) | 2.93290597 |
| 107 | immunoglobulin mediated immune response (GO:0016064) | 2.92937259 |
| 108 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92920144 |
| 109 | response to protozoan (GO:0001562) | 2.92432291 |
| 110 | T cell selection (GO:0045058) | 2.92341955 |
| 111 | myeloid dendritic cell differentiation (GO:0043011) | 2.92077105 |
| 112 | cellular response to growth hormone stimulus (GO:0071378) | 2.92029952 |
| 113 | regulation of isotype switching (GO:0045191) | 2.91527948 |
| 114 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.90224620 |
| 115 | response to interferon-alpha (GO:0035455) | 2.90076638 |
| 116 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.89786331 |
| 117 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.89241417 |
| 118 | negative regulation of type 2 immune response (GO:0002829) | 2.88596353 |
| 119 | myeloid leukocyte activation (GO:0002274) | 2.88179964 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87946529 |
| 121 | response to inactivity (GO:0014854) | 2.87677787 |
| 122 | neutrophil activation involved in immune response (GO:0002283) | 2.87649096 |
| 123 | regulation of macrophage cytokine production (GO:0010935) | 2.87323119 |
| 124 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.86752118 |
| 125 | regulation of interleukin-12 production (GO:0032655) | 2.84416681 |
| 126 | positive regulation of macrophage activation (GO:0043032) | 2.81166757 |
| 127 | negative thymic T cell selection (GO:0045060) | 2.81109443 |
| 128 | positive regulation of tolerance induction (GO:0002645) | 2.80372527 |
| 129 | positive regulation of neutrophil migration (GO:1902624) | 2.78550418 |
| 130 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.78550418 |
| 131 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.75863251 |
| 132 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.75863251 |
| 133 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.74420279 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74209785 |
| 135 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.74184970 |
| 136 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.73103143 |
| 137 | natural killer cell mediated immunity (GO:0002228) | 2.73103143 |
| 138 | lymphocyte costimulation (GO:0031294) | 2.72713032 |
| 139 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72432711 |
| 140 | cellular response to interleukin-15 (GO:0071350) | 2.71833963 |
| 141 | detection of external biotic stimulus (GO:0098581) | 2.71543602 |
| 142 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.70736749 |
| 143 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.70346818 |
| 144 | T cell differentiation involved in immune response (GO:0002292) | 2.69525814 |
| 145 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.69525814 |
| 146 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.69525814 |
| 147 | regulation of respiratory burst (GO:0060263) | 2.69021315 |
| 148 | response to interleukin-15 (GO:0070672) | 2.67338484 |
| 149 | positive regulation by symbiont of host defense response (GO:0052509) | 2.65943225 |
| 150 | modulation by symbiont of host defense response (GO:0052031) | 2.65943225 |
| 151 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.65943225 |
| 152 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.65943225 |
| 153 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.65943225 |
| 154 | modulation by symbiont of host immune response (GO:0052553) | 2.65943225 |
| 155 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.65386977 |
| 156 | interferon-gamma production (GO:0032609) | 2.65358391 |
| 157 | negative T cell selection (GO:0043383) | 2.65103391 |
| 158 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.64547682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.89056273 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.37422774 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.86375598 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.40734503 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.33446662 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.51613338 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.43211423 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.39303126 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12299186 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04848163 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.03969619 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.95626984 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88079344 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.86159953 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.79149852 |
| 16 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.77195850 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.52641666 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.41195731 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.29917055 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.26151737 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.13944030 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.00740584 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99305974 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96491579 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.94482953 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92156682 |
| 27 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91827638 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.81745005 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76464832 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.73011749 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68560293 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63925257 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63239211 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61959436 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60326425 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54009014 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52292860 |
| 38 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.50434555 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49891622 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49430802 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49027014 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48832437 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47747289 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46676134 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45521991 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43655482 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42285468 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40798350 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38062590 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35970126 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35304037 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34771520 |
| 53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34178081 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32311862 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29098448 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24861400 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.24535762 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24082707 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23923541 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20202060 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19669994 |
| 62 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19631100 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19035403 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18859896 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18083751 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16606334 |
| 67 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16576481 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 1.16558988 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16231319 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14762558 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09207755 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07077312 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07034157 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06203639 |
| 75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05194190 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04041212 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01937115 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01930984 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00901239 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00876968 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 1.00871702 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99032239 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98340913 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98243274 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98202127 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97835080 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96917816 |
| 88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96668215 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96065643 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94554425 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93915705 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93747629 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93592953 |
| 94 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92910306 |
| 95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91941618 |
| 96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91941618 |
| 97 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91646417 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91458144 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89814115 |
| 100 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89315703 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89060730 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87501657 |
| 103 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86252226 |
| 104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85265796 |
| 105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84126032 |
| 106 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83802583 |
| 107 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83802583 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83644088 |
| 109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83624561 |
| 110 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83160671 |
| 111 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.82781718 |
| 112 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82073428 |
| 113 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81601553 |
| 114 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80939491 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80854725 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80346955 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80333218 |
| 118 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77341096 |
| 119 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75128441 |
| 120 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75060283 |
| 121 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.72120745 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67940945 |
| 123 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59310243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.77178892 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.79176547 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.56835681 |
| 4 | MP0004510_myositis | 3.23465284 |
| 5 | * MP0005671_abnormal_response_to | 2.96445332 |
| 6 | MP0006082_CNS_inflammation | 2.89756296 |
| 7 | MP0003436_decreased_susceptibility_to | 2.79838414 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.79752276 |
| 9 | MP0001873_stomach_inflammation | 2.78341437 |
| 10 | MP0001790_abnormal_immune_system | 2.75484417 |
| 11 | MP0005387_immune_system_phenotype | 2.75484417 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.54931350 |
| 13 | MP0001853_heart_inflammation | 2.52219055 |
| 14 | MP0003724_increased_susceptibility_to | 2.51803411 |
| 15 | * MP0009785_altered_susceptibility_to | 2.47215334 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.43702717 |
| 17 | MP0008260_abnormal_autophagy | 2.43330906 |
| 18 | MP0000685_abnormal_immune_system | 2.42501075 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.34524546 |
| 20 | * MP0005025_abnormal_response_to | 2.28800151 |
| 21 | MP0001800_abnormal_humoral_immune | 2.27533944 |
| 22 | MP0002254_reproductive_system_inflammat | 2.25514707 |
| 23 | MP0002419_abnormal_innate_immunity | 2.16127807 |
| 24 | MP0005310_abnormal_salivary_gland | 2.09883766 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.06989642 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.05194667 |
| 27 | MP0002723_abnormal_immune_serum | 2.02608608 |
| 28 | MP0000343_altered_response_to | 2.00423032 |
| 29 | MP0003448_altered_tumor_morphology | 1.96506842 |
| 30 | MP0002933_joint_inflammation | 1.91638693 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.88508442 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.85748188 |
| 33 | MP0001819_abnormal_immune_cell | 1.84822742 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.81660245 |
| 35 | MP0004947_skin_inflammation | 1.78537800 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.77844949 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.70946817 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.70023566 |
| 39 | MP0005451_abnormal_body_composition | 1.68599290 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.57540366 |
| 41 | MP0002132_abnormal_respiratory_system | 1.54573809 |
| 42 | MP0002405_respiratory_system_inflammati | 1.54080838 |
| 43 | MP0004381_abnormal_hair_follicle | 1.52083300 |
| 44 | MP0003690_abnormal_glial_cell | 1.47355804 |
| 45 | MP0000858_altered_metastatic_potential | 1.47291643 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.45030917 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.44033021 |
| 48 | MP0003075_altered_response_to | 1.41113819 |
| 49 | MP0003279_aneurysm | 1.38920845 |
| 50 | MP0003045_fibrosis | 1.38439415 |
| 51 | MP0002006_tumorigenesis | 1.37216843 |
| 52 | MP0000716_abnormal_immune_system | 1.36850080 |
| 53 | MP0001542_abnormal_bone_strength | 1.35015240 |
| 54 | MP0006054_spinal_hemorrhage | 1.34464281 |
| 55 | MP0008469_abnormal_protein_level | 1.33626303 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.32761586 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.32341520 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.31778790 |
| 59 | MP0002398_abnormal_bone_marrow | 1.30424987 |
| 60 | MP0005023_abnormal_wound_healing | 1.27216274 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.26023875 |
| 62 | MP0009764_decreased_sensitivity_to | 1.23665050 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.23095921 |
| 64 | MP0005275_abnormal_skin_tensile | 1.21188567 |
| 65 | MP0009278_abnormal_bone_marrow | 1.20962382 |
| 66 | MP0000604_amyloidosis | 1.20651333 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.20303174 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.18127801 |
| 69 | MP0000249_abnormal_blood_vessel | 1.14683101 |
| 70 | MP0001958_emphysema | 1.14058400 |
| 71 | MP0005164_abnormal_response_to | 1.11653478 |
| 72 | MP0001663_abnormal_digestive_system | 1.11246239 |
| 73 | MP0001881_abnormal_mammary_gland | 1.10731643 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.10421453 |
| 75 | MP0001348_abnormal_lacrimal_gland | 1.08882323 |
| 76 | MP0005166_decreased_susceptibility_to | 1.07757043 |
| 77 | MP0004883_abnormal_blood_vessel | 1.06754920 |
| 78 | MP0002429_abnormal_blood_cell | 1.03569788 |
| 79 | MP0008004_abnormal_stomach_pH | 1.03477711 |
| 80 | MP0001545_abnormal_hematopoietic_system | 1.02654065 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.02654065 |
| 82 | MP0005390_skeleton_phenotype | 1.01304222 |
| 83 | MP0002722_abnormal_immune_system | 1.00720579 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.99664934 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.95893377 |
| 86 | MP0004084_abnormal_cardiac_muscle | 0.95316734 |
| 87 | MP0005165_increased_susceptibility_to | 0.95027473 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.94505498 |
| 89 | MP0005174_abnormal_tail_pigmentation | 0.93950365 |
| 90 | MP0003795_abnormal_bone_structure | 0.92540671 |
| 91 | MP0000689_abnormal_spleen_morphology | 0.91869092 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.91267380 |
| 93 | MP0010307_abnormal_tumor_latency | 0.90981209 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.90122185 |
| 95 | MP0001851_eye_inflammation | 0.88512627 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.88113094 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.86621322 |
| 98 | MP0000490_abnormal_crypts_of | 0.85946304 |
| 99 | MP0003866_abnormal_defecation | 0.84660738 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.82905211 |
| 101 | MP0004130_abnormal_muscle_cell | 0.81966130 |
| 102 | MP0009763_increased_sensitivity_to | 0.81000595 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 0.79973866 |
| 104 | MP0004484_altered_response_of | 0.78549298 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.77878143 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76280061 |
| 107 | MP0008874_decreased_physiological_sensi | 0.75786735 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.74750683 |
| 109 | MP0003787_abnormal_imprinting | 0.73886604 |
| 110 | MP0000627_abnormal_mammary_gland | 0.73510729 |
| 111 | MP0003091_abnormal_cell_migration | 0.73383410 |
| 112 | MP0008775_abnormal_heart_ventricle | 0.73078054 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.72823312 |
| 114 | MP0001986_abnormal_taste_sensitivity | 0.72649428 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.71384741 |
| 116 | MP0002009_preneoplasia | 0.71149798 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.70258199 |
| 118 | MP0003828_pulmonary_edema | 0.69376408 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.68650269 |
| 120 | MP0002133_abnormal_respiratory_system | 0.66319050 |
| 121 | MP0005388_respiratory_system_phenotype | 0.66319050 |
| 122 | MP0000013_abnormal_adipose_tissue | 0.65061875 |
| 123 | MP0000920_abnormal_myelination | 0.64290695 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.63585281 |
| 125 | MP0003329_amyloid_beta_deposits | 0.61064244 |
| 126 | MP0003806_abnormal_nucleotide_metabolis | 0.58045690 |
| 127 | MP0003252_abnormal_bile_duct | 0.54972150 |
| 128 | MP0009115_abnormal_fat_cell | 0.54547018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Optic neuritis (HP:0100653) | 6.74570265 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 6.74570265 |
| 3 | Orchitis (HP:0100796) | 6.53885137 |
| 4 | Myositis (HP:0100614) | 5.95853213 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.67698635 |
| 6 | Keratoconjunctivitis sicca (HP:0001097) | 4.61867351 |
| 7 | Pulmonary infiltrates (HP:0002113) | 4.55480416 |
| 8 | Hemoptysis (HP:0002105) | 4.39124125 |
| 9 | Keratoconjunctivitis (HP:0001096) | 4.15560682 |
| 10 | Arterial thrombosis (HP:0004420) | 4.14270918 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 4.13163838 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.13163838 |
| 13 | Vasculitis (HP:0002633) | 4.06133147 |
| 14 | Gangrene (HP:0100758) | 4.01828263 |
| 15 | Obstructive lung disease (HP:0006536) | 3.96326028 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.96326028 |
| 17 | Pulmonary embolism (HP:0002204) | 3.94611773 |
| 18 | T lymphocytopenia (HP:0005403) | 3.76611898 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.72097171 |
| 20 | Chest pain (HP:0100749) | 3.66775500 |
| 21 | Abnormality of the prostate (HP:0008775) | 3.57529821 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.56779582 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.47740785 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.45942570 |
| 25 | Abnormality of the pericardium (HP:0001697) | 3.40515498 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.38836094 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 3.27955394 |
| 28 | Aortic dissection (HP:0002647) | 3.27847146 |
| 29 | Spondylolisthesis (HP:0003302) | 3.27416069 |
| 30 | Amyloidosis (HP:0011034) | 3.21715633 |
| 31 | Meningitis (HP:0001287) | 3.17679393 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.17189413 |
| 33 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.13075043 |
| 34 | Recurrent bronchitis (HP:0002837) | 3.11420002 |
| 35 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.11321915 |
| 36 | Osteolytic defects of the hand bones (HP:0009699) | 3.11321915 |
| 37 | Petechiae (HP:0000967) | 3.09842322 |
| 38 | Thrombophlebitis (HP:0004418) | 3.01374094 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.01138569 |
| 40 | Purpura (HP:0000979) | 2.95887686 |
| 41 | Abnormality of the pleura (HP:0002103) | 2.94943753 |
| 42 | Glomerulopathy (HP:0100820) | 2.92464560 |
| 43 | Gingival bleeding (HP:0000225) | 2.92374181 |
| 44 | Ureteral stenosis (HP:0000071) | 2.91939607 |
| 45 | Cellulitis (HP:0100658) | 2.86189573 |
| 46 | Ureteral obstruction (HP:0006000) | 2.84985745 |
| 47 | Encephalitis (HP:0002383) | 2.81258330 |
| 48 | Anorexia (HP:0002039) | 2.79314134 |
| 49 | Chronic otitis media (HP:0000389) | 2.79179970 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79068252 |
| 51 | Polyneuropathy (HP:0001271) | 2.77117641 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.76105887 |
| 53 | Aortic aneurysm (HP:0004942) | 2.69213928 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.66640263 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.64356420 |
| 56 | Inflammation of the large intestine (HP:0002037) | 2.61651559 |
| 57 | Mediastinal lymphadenopathy (HP:0100721) | 2.57764242 |
| 58 | Cerebral aneurysm (HP:0004944) | 2.55328932 |
| 59 | Episodic fever (HP:0001954) | 2.52173492 |
| 60 | Nasal polyposis (HP:0100582) | 2.50041284 |
| 61 | Fatigue (HP:0012378) | 2.48987650 |
| 62 | Osteomyelitis (HP:0002754) | 2.48119862 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.46127860 |
| 64 | Pustule (HP:0200039) | 2.45076731 |
| 65 | Cerebral ischemia (HP:0002637) | 2.44576656 |
| 66 | Abnormality of the nasal mucosa (HP:0000433) | 2.43816272 |
| 67 | Abnormality of the peritoneum (HP:0002585) | 2.43372802 |
| 68 | Persistence of primary teeth (HP:0006335) | 2.43199297 |
| 69 | Pancreatitis (HP:0001733) | 2.41204275 |
| 70 | Stomatitis (HP:0010280) | 2.40987876 |
| 71 | Myocardial infarction (HP:0001658) | 2.39268814 |
| 72 | Recurrent viral infections (HP:0004429) | 2.37507296 |
| 73 | Dysostosis multiplex (HP:0000943) | 2.35970444 |
| 74 | Colitis (HP:0002583) | 2.35071454 |
| 75 | Gingivitis (HP:0000230) | 2.34339890 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.30435271 |
| 77 | Arterial tortuosity (HP:0005116) | 2.29971131 |
| 78 | Hematochezia (HP:0002573) | 2.28656772 |
| 79 | Absent frontal sinuses (HP:0002688) | 2.28483803 |
| 80 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25693625 |
| 81 | Mucopolysacchariduria (HP:0008155) | 2.25693625 |
| 82 | Increased IgM level (HP:0003496) | 2.25206449 |
| 83 | Epistaxis (HP:0000421) | 2.25190797 |
| 84 | Peritonitis (HP:0002586) | 2.24068231 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 2.23624156 |
| 86 | Cheilitis (HP:0100825) | 2.21301148 |
| 87 | Chronic sinusitis (HP:0011109) | 2.21080029 |
| 88 | Granulocytopenia (HP:0001913) | 2.20336162 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 2.20299113 |
| 90 | Abnormality of glycolipid metabolism (HP:0010969) | 2.12637958 |
| 91 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.12637958 |
| 92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.12637958 |
| 93 | Viral hepatitis (HP:0006562) | 2.12098671 |
| 94 | Recurrent skin infections (HP:0001581) | 2.11739146 |
| 95 | Premature rupture of membranes (HP:0001788) | 2.11418997 |
| 96 | Amaurosis fugax (HP:0100576) | 2.11116039 |
| 97 | Abnormality of the endocardium (HP:0004306) | 2.09615514 |
| 98 | Eosinophilia (HP:0001880) | 2.08210560 |
| 99 | Vascular tortuosity (HP:0004948) | 2.08163610 |
| 100 | Sepsis (HP:0100806) | 2.07679699 |
| 101 | Vertigo (HP:0002321) | 2.06862506 |
| 102 | Hypochromic microcytic anemia (HP:0004840) | 2.06484052 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 2.06340885 |
| 104 | Asymmetric septal hypertrophy (HP:0001670) | 2.05440408 |
| 105 | Loss of speech (HP:0002371) | 2.05174439 |
| 106 | Hypochromic anemia (HP:0001931) | 2.04519694 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04014530 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04014530 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04014530 |
| 110 | Skin ulcer (HP:0200042) | 2.03055819 |
| 111 | Paresthesia (HP:0003401) | 2.02705718 |
| 112 | Hypergammaglobulinemia (HP:0010702) | 2.00808372 |
| 113 | Restrictive lung disease (HP:0002091) | 2.00792462 |
| 114 | Acute hepatic failure (HP:0006554) | 2.00408818 |
| 115 | Periodontitis (HP:0000704) | 2.00006822 |
| 116 | Increased IgE level (HP:0003212) | 1.96761218 |
| 117 | Subacute progressive viral hepatitis (HP:0006572) | 1.95673325 |
| 118 | Abnormality of T cell number (HP:0011839) | 1.93338893 |
| 119 | Slow saccadic eye movements (HP:0000514) | 1.92892304 |
| 120 | Emphysema (HP:0002097) | 1.92717353 |
| 121 | Abnormality of T cell physiology (HP:0011840) | 1.91559415 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.91070744 |
| 123 | Keratitis (HP:0000491) | 1.90384465 |
| 124 | Skin rash (HP:0000988) | 1.90325745 |
| 125 | Leukocytosis (HP:0001974) | 1.89142611 |
| 126 | Autoimmune hemolytic anemia (HP:0001890) | 1.89132587 |
| 127 | Tetraparesis (HP:0002273) | 1.88672058 |
| 128 | Abnormality of T cells (HP:0002843) | 1.87861625 |
| 129 | Malnutrition (HP:0004395) | 1.87598483 |
| 130 | Polycythemia (HP:0001901) | 1.87594291 |
| 131 | Arthralgia (HP:0002829) | 1.86407877 |
| 132 | Glomerulonephritis (HP:0000099) | 1.85545287 |
| 133 | Porencephaly (HP:0002132) | 1.85503513 |
| 134 | Acne (HP:0001061) | 1.85235360 |
| 135 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85023498 |
| 136 | Urticaria (HP:0001025) | 1.83737598 |
| 137 | Recurrent pneumonia (HP:0006532) | 1.82203840 |
| 138 | Lymphopenia (HP:0001888) | 1.81960207 |
| 139 | Microcytic anemia (HP:0001935) | 1.80666441 |
| 140 | Disinhibition (HP:0000734) | 1.79371125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 9.03540190 |
| 2 | TYK2 | 2.86544822 |
| 3 | JAK3 | 2.77141630 |
| 4 | JAK1 | 2.73932420 |
| 5 | TBK1 | 2.47724445 |
| 6 | MAP3K14 | 2.44078269 |
| 7 | TGFBR2 | 2.37418676 |
| 8 | TAOK3 | 2.28274320 |
| 9 | IKBKE | 2.19562506 |
| 10 | EPHB1 | 2.18581004 |
| 11 | MAP4K1 | 2.15740753 |
| 12 | FGFR4 | 2.12672010 |
| 13 | PRPF4B | 2.07483541 |
| 14 | ERN1 | 2.06567387 |
| 15 | IRAK4 | 2.02977340 |
| 16 | KIT | 1.90678761 |
| 17 | EPHA3 | 1.84601610 |
| 18 | ZAP70 | 1.78888890 |
| 19 | TTN | 1.72349298 |
| 20 | FGFR3 | 1.70418103 |
| 21 | MYLK | 1.66193598 |
| 22 | TRIB3 | 1.63956370 |
| 23 | JAK2 | 1.62622152 |
| 24 | BLK | 1.43612313 |
| 25 | YES1 | 1.42403243 |
| 26 | PBK | 1.41289122 |
| 27 | TNK2 | 1.41004195 |
| 28 | BMPR2 | 1.40069712 |
| 29 | ITK | 1.39392721 |
| 30 | IKBKB | 1.36441851 |
| 31 | IRAK3 | 1.35959853 |
| 32 | KSR2 | 1.34545429 |
| 33 | DMPK | 1.33596685 |
| 34 | CSK | 1.21177348 |
| 35 | TEC | 1.19403218 |
| 36 | IRAK1 | 1.15528365 |
| 37 | LCK | 1.15455284 |
| 38 | HCK | 1.15186361 |
| 39 | TAOK1 | 1.12445413 |
| 40 | SYK | 1.08516498 |
| 41 | PIM2 | 1.07180418 |
| 42 | RIPK1 | 1.05909810 |
| 43 | NEK9 | 1.05882080 |
| 44 | STK10 | 1.01650680 |
| 45 | BTK | 1.00106271 |
| 46 | CHUK | 0.98201617 |
| 47 | CAMKK2 | 0.97235252 |
| 48 | MAP3K11 | 0.96857643 |
| 49 | MAP3K6 | 0.94873229 |
| 50 | CDK19 | 0.87755183 |
| 51 | RIPK4 | 0.86090193 |
| 52 | MAP3K13 | 0.83784301 |
| 53 | MARK2 | 0.81136112 |
| 54 | TRPM7 | 0.80116258 |
| 55 | PIK3CG | 0.79024575 |
| 56 | LRRK2 | 0.78913315 |
| 57 | MAP3K10 | 0.77886555 |
| 58 | PTK6 | 0.74586323 |
| 59 | MAP2K3 | 0.74573830 |
| 60 | STK24 | 0.74025322 |
| 61 | SGK3 | 0.70533813 |
| 62 | MAP3K3 | 0.70132286 |
| 63 | PTK2B | 0.69875365 |
| 64 | SIK3 | 0.67891515 |
| 65 | PKN2 | 0.67478144 |
| 66 | BMX | 0.66746268 |
| 67 | MARK3 | 0.65808249 |
| 68 | FES | 0.64753746 |
| 69 | SGK2 | 0.64697935 |
| 70 | MAP2K4 | 0.64640093 |
| 71 | NLK | 0.63265953 |
| 72 | CDC42BPA | 0.62854628 |
| 73 | PIM1 | 0.62827733 |
| 74 | KSR1 | 0.62113511 |
| 75 | MAPK7 | 0.59712666 |
| 76 | KDR | 0.58923245 |
| 77 | WNK1 | 0.58029345 |
| 78 | RAF1 | 0.57491313 |
| 79 | CDK6 | 0.57267370 |
| 80 | MAPK12 | 0.56753486 |
| 81 | PDGFRA | 0.55864329 |
| 82 | STK11 | 0.54528892 |
| 83 | PRKCQ | 0.53165958 |
| 84 | STK4 | 0.51935450 |
| 85 | RPS6KA4 | 0.51502637 |
| 86 | CAMKK1 | 0.50246655 |
| 87 | MAP3K7 | 0.49141803 |
| 88 | TESK1 | 0.48031385 |
| 89 | FLT3 | 0.47803296 |
| 90 | LYN | 0.47774337 |
| 91 | MAPKAPK3 | 0.47667461 |
| 92 | ACVR1B | 0.47291438 |
| 93 | MAPKAPK2 | 0.47021806 |
| 94 | STK3 | 0.46599015 |
| 95 | MATK | 0.45946161 |
| 96 | ABL1 | 0.44811138 |
| 97 | PDPK1 | 0.44713729 |
| 98 | GRK7 | 0.43209983 |
| 99 | MST4 | 0.43087589 |
| 100 | GRK5 | 0.42787750 |
| 101 | IRAK2 | 0.42658765 |
| 102 | PDGFRB | 0.41823420 |
| 103 | CSF1R | 0.41551298 |
| 104 | PDK1 | 0.40613819 |
| 105 | HIPK2 | 0.38245644 |
| 106 | FYN | 0.38081312 |
| 107 | FGR | 0.37988568 |
| 108 | FRK | 0.37967051 |
| 109 | PRKCH | 0.37445878 |
| 110 | ALK | 0.37087048 |
| 111 | RET | 0.36678015 |
| 112 | ILK | 0.34744633 |
| 113 | MAP3K12 | 0.34446969 |
| 114 | MAPK11 | 0.34424491 |
| 115 | MAP3K5 | 0.34129405 |
| 116 | MAP3K1 | 0.33649660 |
| 117 | TAOK2 | 0.33524173 |
| 118 | MAPK4 | 0.33509730 |
| 119 | PRKD2 | 0.32902646 |
| 120 | MAP2K6 | 0.31972011 |
| 121 | RPS6KL1 | 0.31933509 |
| 122 | RPS6KC1 | 0.31933509 |
| 123 | EGFR | 0.31664521 |
| 124 | MAP3K2 | 0.31321640 |
| 125 | MOS | 0.30822227 |
| 126 | DAPK2 | 0.30270244 |
| 127 | NUAK1 | 0.29598135 |
| 128 | CAMK4 | 0.29116603 |
| 129 | GSK3A | 0.28016823 |
| 130 | IGF1R | 0.25438827 |
| 131 | LMTK2 | 0.25286027 |
| 132 | GRK6 | 0.24097557 |
| 133 | DAPK3 | 0.23321536 |
| 134 | PAK2 | 0.22027553 |
| 135 | DYRK1B | 0.21950869 |
| 136 | PTK2 | 0.21486343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.86618677 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.79902340 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.48683100 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.17162050 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.99694258 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77393241 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.76370118 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16812368 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09164945 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00032179 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.91253340 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.86662894 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86258141 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.84018241 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.79109221 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.67708475 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.60339485 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.58760175 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.56594173 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55393254 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54932038 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49565017 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49180747 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48160831 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41774114 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38943128 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.36524809 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34277619 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30967359 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.29427821 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27074407 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24057660 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23228555 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.19060880 |
| 35 | Amoebiasis_Homo sapiens_hsa05146 | 1.18285312 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.16257280 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14805638 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13617149 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10038632 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.09035616 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.08291998 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06997091 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03513229 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00940273 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99812725 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98412172 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.98013305 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95737456 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.92505835 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84191377 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83988204 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83316927 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83158027 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.81334085 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.80192583 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78686507 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76639485 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75568731 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.73245871 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71783498 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70216879 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69869107 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68509309 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66211064 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65558695 |
| 66 | Focal adhesion_Homo sapiens_hsa04510 | 0.64900658 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64606553 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63763536 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61939407 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61551238 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58502890 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58183175 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57684644 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55206507 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55189600 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54479603 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54333707 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52880989 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52279452 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52163647 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51577744 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50402185 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49158570 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49083121 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49018816 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47902805 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47579227 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45820226 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45098115 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44451861 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43337976 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42243170 |
| 93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41607521 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41191218 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.39849248 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39584053 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38874933 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37277698 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34837756 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34382151 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34328327 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32505773 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32350085 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32334172 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31499233 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28358830 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.28286326 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28208062 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28037057 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.28022466 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27931002 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26944935 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26781847 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25070051 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24399577 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20319784 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19909230 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.19433383 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19036186 |
| 120 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17918594 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.17896088 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16969669 |

